Intriguingly, they found that ARCC‐4 induced the degradation of AR mutants including F876L, H874Y, M896V, T877A, and L702H.67 Their studies based on cells provided hopes to cure AR mutant prostate cancers. This evidence concerns the gene AR and prostate cancer.